Testone CIK (Page 3 of 3)
HOW SUPPLIED
Testosterone Cypionate Injection, USP, 200 mg/mL is available as follows:
1 mL vials NDC 0574-0820-01
Vials should be stored at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light. Use carton to protect contents from light until used.
This product’s label may have been updated. For current full prescribing information, please visit www.perrigo.com.
Manufactured By
PharmaForce, Inc.
Hilliard, OH 43026
Manufactured For
Perrigo®
Minneapolis, MN 55427
9Z800 RC J8
Rev 12-16 G
Isopropyl Alcohol 70% Prep Pad
Active Ingredient Purpose
Isopropyl Alcohol 70% v/v Antiseptic
Use:
For preparation of the skin prior to injection.
Warnings:
- For external use only
- Flammable, keep away from flame or fire
- Not for use with electrocautinary devices or procedures
- Do not use in eyes
Stop use and ask a doctor if:
- Irritation or redness develops
- condition persists for more than 72 hours
- Cleansing of an injection site
Keep out of reach of children.
In case of accidental ingestion, seek professional assistance or consult a poison control center immediately.
Directions:
Wipe injection site vigorously and discard
Other information:
- Store at room temperature: 15 deg C to 30 deg C 59 deg F to 86 deg F
- avoid excessive heat
Inactive Ingredient
Inactive Ingredient
- Water
Principal Display Panel
NDC: 76420-650-01
RX-Only
Testone CIK™ CIII
Kit Contains
1 Testosterone Cypionate Injection, USP 200mg/mL (1mL)
1 Isopropyl Alcohol 70% Prep Pad
1 Pair Nitrile Powder Free Sterile Gloves (M)
1 Drape
1 Adhesive Bandage
5 Non Sterile 4×4 Gauze
Needles and Syringes Not Included
1 Dose
Single Use Only
Distributed by:
Enovachem™
PHARMACEUTICALS
Torrance, CA 90501
TESTONE CIK testosterone cypionate, alcohol kit | |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
| |||||||||||||||||
|
Labeler — Asclemed USA, Inc. (059888437) |
Revised: 09/2020 Asclemed USA, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.